June 22, 2016
Takao Hayakawa, professor of pharmacology at Kindai University, was elected as director general of the Chemo-Sero-Therapeutic Research Institute, an embattled vaccine and blood product maker known as Kaketsuken, effective June 19. Dr Hayakawa will take over the role from Seiji...read more